GlassScriptPhysician profile
Todd Hayashida Driver
NPI 1245650985
$3,375.44
in general payments reported to CMS, 2019-2025
24 companies · $533 in 2025
The $533 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.74 · 2020: $92.45 · 2021: $672 · 2022: $585 · 2023: $817 · 2024: $651 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,970 · Entertainment: $31.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,969.56 |
| Entertainment | $31.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $849.62 | 2021-2025 | Argos, Rocklatan, Simbrinza |
| Johnson & Johnson Surgical Vision, INC. | $569.35 | 2022-2025 | Tecnis Iol, Catalys System, Veritas Vision System |
| Rxsight INC | $248.03 | 2020-2024 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Glaukos Corporation | $233.74 | 2021-2025 | Idose, Idosetr, Istent Infinite |
| Sight Sciences, INC. | $156.04 | 2024 | Omni Surgical System |
| Spark Therapeutics, INC. | $125.00 | 2021 | |
| Horizon Therapeutics Plc | $123.43 | 2021 | |
| Genentech USA, INC. | $105.60 | 2021 | |
| Bausch & Lomb Americas INC. | $103.90 | 2022-2025 | Miebo, Vyzulta |
| Harrow Eye, LLC | $90.72 | 2025 | Vevye, Iheezo |
| Novartis Pharmaceuticals Corporation | $86.11 | 2020-2023 | |
| Thea Pharma INC. | $83.88 | 2022-2025 | Iyuzeh |
| Sun Pharmaceutical Industries INC. | $77.58 | 2024-2025 | |
| Lensar, INC. | $75.80 | 2024 | Lensar Laser System |
| Abbvie INC. | $74.29 | 2022-2024 | Alphagan P, Lumigan |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $59.08 | 2022-2023 | Tyrvaya |
| Allergan, INC. | $58.58 | 2021 | |
| Amgen INC. | $56.70 | 2024-2025 | Tepezza |
| Aerie Pharmaceuticals, INC. | $53.38 | 2020-2021 | |
| Rayner Intraocular Lenses Limited | $48.40 | 2025 | Omidria |
| Optos, INC. | $31.28 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.74 | 2019 | |
| Eyevance Pharmaceuticals LLC | $20.79 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Driver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.